BIO commends the government of Colombia for taking steps towards developing regulatory requirements for the registry of medicines of...
February 22 2013
BIO commends the INPI for their efforts to devise guidelines for examining biotechnology related inventions. Given the technological...
February 1 2013
The House Judiciary Committee conducted a hearing on World IP Day on "International Patent Issues: Promoting...
April 25 2012
Selected Excerpts:
The vast majority of BIO’s members are small and medium sized enterprises that currently do not have products...
March 7 2012
BIO has identified the following countries of interest and recommends the following for our 2011 Special 301 submission.
Priority...
February 14 2012
By Electronic Submission
Ip.policy@uspto.gov
Office of Policy and External Affairs
United States Patent and Trademark Office...
November 10 2011
April 1, 2011
Re: Request for Comments on the Strategy for American Innovation
Subject: Innovation Strategy RFI
Email: competitiveness@doc.gov
Dear...
April 1 2011
June 22, 2007
I'm writing on behalf of the Biotechnology Industry Organization (BIO) in response to your invitation for public comments on...
June 22 2007
October 6, 2006
Perhaps no other industry is as dependent upon patents as is the biotech industry. In 2004 alone, more than 10% of the PTO's...
October 6 2006
October 24, 2003
Dear House Leadership:
On behalf of the Biotechnology Industry Organization (BIO), I urge you to seek prompt passage of H.R. 1561, the...
October 24 2003
May 6, 2002
Under Secretary of Commerce for Intellectual Property and Director of the USPTO on Patent Harmonization
May 6 2002
May 4, 2001
Acting Undersecretary of Commerce and Acting Director of the United States Patent and Trademark Office Regarding Patent Law Harmonization
May 4 2001